Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2025
Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre-Treatment Platelet Counts: A Retrospective Multicenter StudyTakayoshi Suga, Satoru Kakizaki, Atsushi Naganuma, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm StudyTakeshi Hatanaka, Satoru Kakizaki, Naoto Saito, et al.
DEN Open|March 21, 2022
Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antiviralsSatoshi Takakusagi, Naoto Saito, Takashi Ueno, et al.
In Vivo (Athens, Greece)|December 28, 2018
β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular CarcinomaAtsushi Naganuma, Takashi Hoshino, Nozomi Ohno, et al.
Drug Metabolism and Pharmacokinetics|November 3, 2009
Novel large-scale deletion (whole exon 7) in the ABCC2 gene in a patient with the Dubin-Johnson syndromeDaisuke Kanda, Hitoshi Takagi, Yasutsugu Kawahara, et al.
Clinical Case Reports|July 28, 2022
A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumabNaoto Saito, Takeshi Hatanaka, Sachi Nakano, et al.
Cancers|November 11, 2022
Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after HepatectomyMasaki Kaibori, Kengo Yoshii, Kosuke Matsui, et al.
Liver Cancer|December 7, 2023
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment ModalityAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2021
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed AppropriatelyHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 22, 2019
Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failureHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.
Pageof 17